Luis Granero

Prof. Luis Granero

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2003 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Closed access
PDF file
Maria Jose Cano-CebrianMaria Jose Cano-Cebrian
Maria Jose Cano-Cebrian
TZT Zornoza-Sabina
T Zornoza-Sabina
CGC Guerri
C Guerri
APA Polache
A Polache
LGLuis Granero
Luis Granero

1 December 2003 in CNS Drug Reviews
Verified
Journal Article
Open access
PDF file
TZTeodoro Zornoza
Teodoro Zornoza
Maria Jose Cano-CebrianMaria Jose Cano-Cebrian
Maria Jose Cano-Cebrian
APAna Polache
Ana Polache
LGLuis Granero
Luis Granero
In the last years important advances have been made in the development of drugs for the treatment of alcohol addiction. Acamprosate (calcium bis‐acetylhomotaurine) is one of the better established drugs in this field on the European market. This review focuses first on the pharmacokinetics of acamprosate. The published data and the recent advances in our knowledge on the mechanisms involved in the intestinal absorption and elimination of this drug are summarized. The importance of pharmacokinetics for the proper clinical use of acamprosate is highlighted. The anti‐relapse as well as the well‐known effects of acamprosate on ethanol intake are discussed. The recent experiments in animal models of conditioned withdrawal are reviewed. These experiments, explored for the first time the anticraving effect of the drug. Finally, the proposed hypotheses on the neuropharmacological mechanism of action of acamprosate are discussed. The discussion deals with the relative importance of various hypotheses as well as with the recent experiments that support them. It is pointed out that further research is necessary in order to clearly understand the mode of action of acamprosate as well as the neurobiological mechanisms involved in alcohol dependence.

1 April 2005 in Current Drug Metabolism
Verified
Journal Article
Closed access
PDF file
Maria Jose Cano-CebrianMaria Jose Cano-Cebrian
Maria Jose Cano-Cebrian
TZT. Zornoza
T. Zornoza
APA. Polache
A. Polache
LGLuis Granero
Luis Granero
This paper reviews the empirical methods of quantitative microdialysis that have been used to interpret the results obtained from pharmacokinetic studies. The concept of extraction efficiency or recovery and the properties of recovery in vivo (variation with flow rate, time dependency and influence of the mode of administration) are considered. The most frequently used methods for determining recovery in vivo are described and evaluated in the light of recent theoretical studies. Specifically, we review the variation of flow rate method, the very slow flow method, the no net flux method and the delivery and retrodialysis methods. Special emphasis is placed on the description of each method, demonstrating its applicability to pharmacokinetic studies conducted under steady-state or transient conditions, and also its limitations. Finally, the more relevant studies that have compared the suitability of these methods are reviewed.

1 October 2010 in Neuroscience Letters
Verified
Journal Article
Closed access
LMLucía Martí-Prats
Lucía Martí-Prats
MSMaría José Sánchez-Catalán
María José Sánchez-Catalán
LHLucía Hipólito
Lucía Hipólito
AOAlejandro Orrico-Sánchez
Alejandro Orrico-Sánchez
TZTeodoro Zornoza
Teodoro Zornoza
LGLuis Granero
Luis Granero

6 September 2003 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Closed access
PDF file
TZT. Zornoza-Sabina
T. Zornoza-Sabina
CGC. Guerri
C. Guerri
APA. Polache
A. Polache
LGLuis Granero
Luis Granero
Maria Jose Cano-CebrianMaria Jose Cano-Cebrian
Maria Jose Cano-Cebrian

27 July 2015 in Journal of Psychopharmacology
Verified
Journal Article
Closed access
LMLucía Martí-Prats
Lucía Martí-Prats
AOAlejandro Orrico-Sánchez
Alejandro Orrico-Sánchez
APAna Polache
Ana Polache
LGLuis Granero
Luis Granero
A recent hypothesis, based on electrophysiological and behavioural findings, suggests that ethanol simultaneously exerts opposed effects on the activity of dopamine (DA) neurons in the ventral tegmental area (VTA) through two parallel mechanisms, one promoting and the other reducing the GABA release onto VTA DA neurons. In this sense, the activating effects are mediated by salsolinol, a metabolite of ethanol, acting on the μ-opioid receptors (MORs) located in VTA GABA neurons. The inhibitory effects are, however, triggered by the non-metabolized fraction of ethanol which would cause the GABAAreceptors-mediated inhibition of VTA DA neurons. Since both trends tend to offset each other, only the use of appropriate pharmacological tools allows analysis of this phenomenon in depth. Herein, we present new behavioural findings supporting this hypothesis. Motor activity was evaluated in rats after intra-VTA administration of ethanol 35 nmol, an apparently ineffective dose, 24 h after the irreversible blockade of MORs in the VTA with β-FNA. Our results showed that this pre-treatment turned the initially ineffective ethanol dose into a depressant one, confirming that the activating effect of ethanol can be selectively suppressed without affecting the depressant effects mediated by the non-biotransformed fraction of ethanol.